Guang Biao Zhou | Cancer immunology | Best Researcher Award

Published on by Global Academic Awards

Prof. Guang Biao Zhou | Cancer immunology | Best Researcher Award

Prof. Guang Biao Zhou, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, China

Prof. Guang-Biao Zhou is a renowned cancer biologist and Deputy Director of the State Key Laboratory of Molecular Oncology at the National Cancer Center, Chinese Academy of Medical Sciences. His research focuses on 🫁 environmental lung carcinogenesis and cancer therapeutics, exploring the roles of genomic changes and non-coding RNAs in pollution-induced lung cancer. He has identified key factors like AhR, CXCL13, and CDC34 in tobacco and air pollution-related cancer pathways. πŸ“š With over 150 peer-reviewed publications, Dr. Zhou also serves as Executive Deputy Editor-in-Chief of Frontiers of Medicine and CAE Transactions on Medicine.

Publication Profile

Scopus

Orcid

πŸŽ“ Education & Qualifications

Prof. Guang-Biao Zhou earned his MD and Ph.D. in Medicine from the prestigious School of Medicine at Shanghai Jiao Tong University, Shanghai, China πŸ›οΈ. His academic training spanned from August 25, 2000, to July 1, 2003, equipping him with a solid foundation in medical science and research 🧬. This rigorous education laid the groundwork for his future contributions to oncology, particularly in environmental lung carcinogenesis and therapeutic innovation 🫁. Prof. Zhou’s qualifications reflect both academic excellence and a strong commitment to advancing medical knowledge πŸ“š, shaping his path as a leading figure in cancer biology

πŸ’Ό Professional Experience

Prof. Guang-Biao Zhou has held esteemed positions across leading Chinese research institutions. Since October 2018, he has been serving as a Professor at the State Key Laboratory of Molecular Oncology, Cancer Hospital, Chinese Academy of Medical Sciences in Beijing πŸ₯. Prior to this, from 2009 to 2018, he was a Professor at the State Key Laboratory of Membrane Biology, Institute of Zoology, Chinese Academy of Sciences 🧫. His earlier tenure from 2005 to 2009 was at the Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences 🧬, marking a strong trajectory in biomedical research leadership

Research Focus

Prof. Dr. Guang-Biao Zhou is a leading researcher in the fields of lung cancer biology 🫁, molecular oncology 🧬, and immunotherapy πŸ’‰. His work focuses on the molecular mechanisms of tumor progression, such as metabolic reprogramming, apoptosis, and immune regulation. He has contributed to high-impact studies involving non-small cell lung cancer, cancer vaccine development, PD-L2-mediated immune responses, and thalassemia treatments. His interdisciplinary approach bridges genomic regulation, mitochondrial-associated cell death, and drug resistance pathways, aiming to improve prognostic markers and therapeutic targets. Zhou’s research is frequently published in top-tier journals like Molecular Cell, Nature Biomedical Engineering, and Cell Discovery.

Conclusion

Prof. Guang-Biao Zhou is highly suitable for the Research for Best Researcher Award. His work not only advances scientific understanding but also offers practical implications for improving global health outcomes.Β 

Publication Top Notes

  • 🧬 Oncogenic functions and therapeutic potentials of targeted inhibition of SMARCAL1 in small cell lung cancer – Cancer Letters, 2024 | πŸ“… 2024 | DOI: 10.1016/j.canlet.2024.216929

  • ⚑ CIP2A induces PKM2 tetramer formation and oxidative phosphorylation in NSCLC – Cell Discovery, 2024 | πŸ“… 2024 | DOI: 10.1038/s41421-023-00633-0

  • πŸ§ͺ 10,11-Dehydrocurvularin attenuates inflammation via NLRP3 suppression – Chinese Journal of Natural Medicines, 2023 | πŸ“… 2023 | DOI: 10.1016/S1875-5364(23)60418-2

  • 🌫️🧬 Air pollution, EGFR mutation, and cancer initiation – Cell Reports Medicine, 2023 | πŸ“… 2023 | DOI: 10.1016/j.xcrm.2023.101046

  • 🌿✨ Corrigendum: Promising anticancer activities of Centipeda minima compounds – Phytomedicine, 2023 | πŸ“… 2023 | DOI: 10.1016/j.phymed.2022.154472

  • 🧠🧬 Alternative splicing of FAK in pancreatic and breast neuroendocrine tumors – Frontiers of Medicine, 2023 | πŸ“… 2023 | DOI: 10.1007/s11684-023-1009-7

  • πŸ›‘οΈπŸ§« CD47 in tumor immune evasion and targeted therapy – Journal of Sichuan Univ. (Med Sci), 2023 | πŸ“… 2023 | DOI: 10.12182/20230560101

  • πŸ§ͺ🧬 Nuclear AhR and membranous PD-L1 predict PD-1 response in NSCLC – Signal Transduction & Targeted Therapy, 2023 | πŸ“… 2023 | DOI: 10.1038/s41392-023-01416-5

  • πŸš¬πŸ›‘οΈ Tobacco carcinogen induces IDO1 and immune suppression – Signal Transduction & Targeted Therapy, 2022 | πŸ“… 2022 | DOI: 10.1038/s41392-022-01127-3

  • πŸ“’πŸ§¬ Correction: AhR mediates tobacco-induced PD-L1 and immunotherapy response – Nature Communications, 2022 | πŸ“… 2022 | DOI: 10.1038/s41467-022-30871-x

Hyunsook Lee | Cancer Cell Biology | Best Researcher Award

Published on by Global Academic Awards

Prof Dr. Hyunsook Lee | Cancer Cell Biology | Best Researcher Award

Prof Dr. Hyunsook Lee, Seoul National University/College of Natural Sciences/Dept. of Biological Sciences, South Korea

πŸŽ“ Prof. Dr. Hyunsook Lee is an accomplished scientist with a diverse educational background: B.Sc. from Ewha Womans University, M.Sc. from Seoul National University, and a Ph.D. from the University of Cambridge under Prof. Ashok Venkitaraman. Her research focused on cell cycle checkpoints and the breast cancer susceptibility gene, Brca2. Dr. Lee holds key positions including Head of AI-Bio Research Center and Dean for Research Affairs at Seoul National University. She co-founded Next & Bio, later acquired by Kolmar Holdings, and has served on advisory boards for STEPI and the Ministry of Education in Korea. 🧬

 

Publication profile

Google Scholar

πŸŽ“ Education

Prof. Dr. Hyunsook Lee earned her B.Sc. from Ewha Womans University (1986-1990) and M.Sc. from Seoul National University (1990-1992). She completed her Ph.D. at the University of Cambridge (1996-1999), focusing on cell cycle checkpoints and the breast cancer gene, Brca2, under the supervision of Prof. Ashok Venkitaraman.

🌟 Professional Achievements

Dr. Lee holds numerous prestigious positions, including Head of AI-Bio Research Center (since 2023) and co-founder of Next & Bio (acquired by Kolmar Holdings in 2022). She served as Dean for Research Affairs at Seoul National University and on advisory committees for STEPI and the Ministry of Education in Korea.

Experience

Her career includes roles as a Visiting Scientist at Harvard Medical School and the University of Washington, and she contributed significantly to institutions like Samsung Advanced Institute of Technology.

 

Research Focus

Dr. H. Lee’s research spans across several fields, primarily focusing on technological advancements and their impacts. His work includes studies on augmented and virtual reality, high-frequency electrical models, and the application of IT in organizational contexts. With interests ranging from cultural heritage tourism to smart home services, Dr. Lee’s research integrates diverse disciplines to explore innovative solutions and their societal implications. 🌐

Publication Top Notes

πŸ“„ Nature 425 (6961), 968-973 – Fusion of bone-marrow-derived cells with Purkinje neurons, cardiomyocytes and hepatocytes (2152 citations, 2003)

πŸ“Š Public administration review 66 (3), 370-385 – The impact of organizational context and information technology on employee knowledge-sharing capabilities (1149 citations, 2006)

πŸ”¬ Molecular cell 1 (3), 347-357 – Involvement of Brca2 in DNA repair (789 citations, 1998)

πŸ–₯️ IEEE Journal of Solid-state circuits 19 (6), 820-827 – Full-speed testing of A/D converters (702 citations, 1984)

πŸ›οΈ Information and communication technologies in tourism 2016 – Effects of virtual reality and augmented reality on visitor experiences in museums (636 citations, 2016)

🧲 Physical Review Bβ€”Condensed Matter and Materials Physics 72 (17), 174431 – Magnetic ordering at the edges of graphitic fragments (563 citations, 2005)

🧠 Brain research 971 (2), 197-209 – Astrocytes accumulate AΞ²42 and give rise to astrocytic amyloid plaques in Alzheimer disease brains (538 citations, 2003)

πŸ”Œ IEEE Transactions on Components, Packaging and Manufacturing Technology 1 (2) – High-frequency scalable electrical model and analysis of a through silicon via (TSV) (509 citations, 2011)

πŸ—οΈ Cement and Concrete research 32 (8), 1313-1318 – Evaluation of the bond properties between concrete and reinforcement as a function of the degree of reinforcement corrosion (496 citations, 2002)

πŸ›οΈ Journal of Travel Research 57 (5), 627-643 – The role of augmented reality for experience-influenced environments: The case of cultural heritage tourism in Korea (403 citations, 2018)

🏠 Industrial Management & Data Systems 117 (1), 68-89 – User acceptance of smart home services: an extension of the theory of planned behavior (395 citations, 2017)

🌿 Proceedings of the National Academy of Sciences 87 (19), 7633-7637 – Wound-induced accumulation of mRNA containing a hevein sequence in laticifers of rubber tree (362 citations,